IL6 and cardiomyopathy: Interestingly, the levels of both IL‐6 and G‐CSF were significantly increased in all patients compared with controls (Figure 4A, B, Table 2) with the AUC value of 0.94 ± 0.04 (Figure 4A’, p = 0.0003) and 1 (Figure 4B’, p < 0.0001), respectively, indicating the levels of these cytokines as valuable parameters to distinguish between patients affected by LMNA‐associated cardiomyopathy and controls at least in our cohort of 30 individuals analysed.